ClearPoint Neuro (CLPT) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026)
ClearPoint Neuro (CLPT) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 13.22% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 9.93% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 19.89% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 7.35% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 14.29% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 8.56% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 7.10% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 1.61% |
| 10 | ClearPoint Neuro | 431.98 Mn | 396.38 Mn | 7.76 Mn | 33.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.49% |
| Dec 31, 2025 | 30.72% |
| Sep 30, 2025 | 24.72% |
| Jun 30, 2025 | 30.68% |
| Mar 31, 2025 | 62.06% |
| Dec 31, 2024 | 44.35% |
| Sep 30, 2024 | 25.09% |
| Jun 30, 2024 | 13.60% |
| Mar 31, 2024 | 41.94% |
| Dec 31, 2023 | 72.33% |
| Sep 30, 2023 | 115.42% |
| Jun 30, 2023 | 97.39% |
| Mar 31, 2023 | 33.85% |
| Dec 31, 2022 | 49.54% |
| Sep 30, 2022 | 39.78% |
| Jun 30, 2022 | 97.42% |
| Mar 31, 2022 | 142.81% |
| Dec 31, 2021 | 68.97% |
| Sep 30, 2021 | 37.59% |
| Jun 30, 2021 | 1.87% |